Optiv, eye drops, 10 ml

It belongs to the group of ophthalmic agents in combinations, is an artificial analogue of tears.

Carmellose sodium and glycerol have properties of corneal epithelium protector, improve corneal moistening with decreased tear fluid secretion and increase the stability of the tear film.

Indications

Symptomatic treatment for dry eye syndrome.

Active ingredient

Composition

Active ingredients:

sodium carmellose (type 7H3SXF 10-15) 1.75 mg,

sodium carmellose (type 7M8SFPH)3.25 mg,

Glycerol 9mg.

Associates:

Eritritritol 2.50 mg,

levocarnitine 2.50 mg,

boric acid 7.00 mg,

sodium borate decahydrate 2.00 mg,

sodium citrate dihydrate 1.00 mg,

potassium chloride 1.40 mg,

/p>

calcium chloride dihydrate 0.06 mg,

magnesium chloride hexahydrate 0.06 mg,

oxy-chloro complex stabilized [sodium chlorite, sodium chlorate, chlorine dioxide] 0.10 mg,

Purified water to 1.00 ml.

How to take, the dosage

The drug is injected into the conjunctival sac in 1-2 drops as needed.

Interaction

There are no data on drug interactions of Optiv.

When administered with other topical ophthalmic agents, the interval between instillation of Optiv and other eye drops should be at least 5 minutes in order to eliminate the possibility of “washout” of the drug.

Special Instructions

The drug is intended for topical use only.

Do not use if the film on the neck of the bottle has been tampered with, the solution is cloudy or has discolored.

The pipette tip should not be allowed to touch any surface, including the conjunctiva, to avoid contamination of the contents of the bottle. The bottle should be closed immediately after use.

Consult your physician if you experience pain in the eye area, blurred vision, prolonged hyperemia, or irritation of the eye mucosa.

Also consult a physician if there is no improvement from the use of drug 2 and/or if you experience other adverse events that increase or do not resolve within 72 hours.

If you experience blurred vision after installation, you should refrain from driving or engaging in potentially hazardous activities that require increased concentration and quick psychomotor reactions until it has recovered.

Contraindications

With caution: in pregnancy and lactation (due to limited data).

Side effects

The following adverse reactions may occur when using the drug:

Visual disorders: common – conjunctival hyperemia, eyelid hyperemia, blurred vision, dry eye sensation, discomfort when injecting, itching and eye irritation, crusting on the edge of the eyelid.

In the post-marketing period the following adverse reactions to Optiv have been reported (frequency unknown): pain in the eye area, discharge from the eye, foreign body sensation in the eye, swelling of the eyelid, increased tear production, photophobia.

Pregnancy use

The use of the drug during pregnancy and lactation is possible with caution. Strictly controlled studies in pregnant women and nursing mothers have not been conducted.

In animal studies no adverse effects of the active ingredients of the drug were found. Optiv is not absorbed from the mucosal surface, thus there are no objective prerequisites for possible excretion of its components with breast milk.

Prevalence in children

It is contraindicated in children under 18 years of age.